Announcement on Expected Loss in Performance for 2025
Filed with SSE · · 2 pages · Chinese
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Shapuaisi Pharmaceutical
- for Diflunisal Tablets
- Indicative Announcement on Expected Loss in Performance for 2025
- Announcement on Result of Shareholding Reduction by Shareholder through Call Auction
- Announcement on Result of Shareholding Reduction by Shareholder
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
Later from Zhejiang Shapuaisi Pharmaceutical
- Announcement on Receiving Letter of Supervision and Inquiry Regarding Related-Party Asset Purchase of Zhejiang Shapuaisi Pharmaceutical Co., Ltd. from Shanghai Stock Exchange
- Announcement on Receipt of the "Letter of Shareholder Suggestions" from the China Securities Investor Services Center
- Announcement on the Remuneration Plan for Directors and Senior Management Members in 2026
- Announcement on Postponing Reply to Letter of Inquiry from SSE
- Indicative Announcement on Convening the 2025 Annual General Meeting
Follow Zhejiang Shapuaisi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shapuaisi Pharmaceutical